Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
RecruitingNCT06674772
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to visit the study center for sample collection. A sample of blood and saliva will be collected in order to measure CGRP levels and DNA and hormone testing.
Study details
- Official title
- Fenotipado Molecular De Pacientes Con Migraña Según Edad Y Sexo a Través De La Cuantificación De CGRP En Saliva Para Realizar Medicina De Precisión: Estudio FAST
- Conditions
- Headache (Migraine)
- Migraine
- Migraine Headache
- Migraine with Aura
- Migraine Without Aura
- Episodic Migraine
- Chronic Migraine Headache
- Chronic Migraine, Headache
- Episodic Migraine Headache
- Interventions
- Diagnostic test: Saliva test
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Start date
- 2022-11-29
- Primary completion
- 2025-04-30
- Sex
- All
- Age range
- from 6 Years to 75 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Migraine patients according to ICHD-3 criteria * Healthy controls paired to patient age and sex, without headache and without first degree family history of headache. Exclusion Criteria: * Presence of any major medical or neurological illness. * Presence of any salivary gland malfunction. * Abuse or dependence to tobacco, alcohol or any drug in the previous 12 months before the enrollment. * Active migraine preventive treatment. * Pregnant or breastfeeding female.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06674772